Buprenorphine and Office-Based Treatment of Opioid Dependence

Saturday, October 20, 2007
Time: 8:00 AM – 5:30 PM

Judith Martin, MD
The 14th Street Clinic

John Mendelson, MD
California Pacific Medical Research Institute
San Francisco, CA

Karen Miotto, MD
UCLA Department of Psychiatry and Behavioral Sciences
Los Angeles, CA

Edward Moores, M.D.
Beverly Hills, CA

Edwin A. Salsitz, MD
Office-Based Opioid Therapy
New York, NY

The presentation is designed to train qualified physicians in dispensing or prescribing specifically approved Schedule III, IV and V narcotic medications for the treatment of opioid addiction in an office-based setting as part of the Drug Abuse Treatment Act (DATA) 2000.

Physicians qualify after completion of not less than eight (8) hours of approved training. This course satisfies the DATA 2000 eight-hour training requirement. Certificates will be provided to each physician who completes the training confirming the eight hours of training. Certificates may be mailed to the Secretary of Health and Human Services along with a Request for Waiver of the special registration requirements defined in the Controlled Substances Act.

The goal of this program is to acquire the knowledge and skills needed to provide optimal care to opioid dependent patients.

Topics covered in the program are:

• Overview of opioid dependence: Describes the rationale and effectiveness of opioid pharmacotherapy in the treatment of opioid dependence.
• Buprenorphine efficacy and safety: Summarizes the literature on the efficacy and safety of buprenorphine treatment.
• Legislative changes: Summarizes the law, Drug Addiction Treatment Act of 2000 (DATA 2000), that allows for the treatment of opioid dependence in office-based settings.
• Patient selection: Describes the essential aspects of assessing and selecting patients appropriate for office-based opioid treatment.
• Clinical use of buprenorphine: Describes induction, stabilization and maintenance protocols for treating opioid dependent patients with buprenorphine.
• Non-pharmacological interventions: Describes the efficacy, components and role for non-pharmacological treatments for opioid dependence.
• Medical and psychiatric conditions in opioid dependent patients: Summarizes the common medical and psychiatric co-morbidities including HIV/AIDS, hepatitis B and C, depression and anxiety found in opioid dependent patients.
• Special treatment populations: Describes the management of pain in patients with addictive disorders, and the management of adolescents and pregnant women with opioid dependence.
• Office procedures: Describes and be able to apply clinical tools (e.g. treatment contacts, consents and protocols) needed to set up office-based treatment with buprenorphine. Describes the important confidentiality and record keeping requirements for treating opioid dependent patients in office-based settings.

This program is recommended for physicians with experience and/or interest in treating opioid dependence. It is also recommended for primary care, psychiatric, HIV, pain and addiction medicine physicians.

There is a separate registration fee for this session, please contact ASAM at ASAM.org.

Sponsored by the American Society of Addiction Medicine.

Supported by an unrestricted continuing medical educational grant provided by Reckitt Benckiser.